Extracellular Featured in Protein Production Technology International

In the Q4 2024 edition of Protein Production Technology International, Nico Hutton, Chief Commercial Officer at Extracellular, discussed the company’s role in accelerating the commercialisation of cell-cultivated products. By offering expert contract research and manufacturing services, Extracellular helps startups scale from lab to commercial production, avoiding the high costs of pilot-scale facilities.

Nico highlighted the importance of partnerships and specialisation within the industry, noting how Extracellular focuses on cell line suspension adaptation, media optimisation, and bioprocess scaling, allowing clients to concentrate on product development and regulatory approval.

A key success story includes scaling Merck Group’s species-specific media to 200 liters in just five months, reducing costs and timelines by over 70%.

Protein Production Technology International - Q4 2024 edition